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Serine Phosphorylation of the Hepatitis C Virus NS5A Protein
Controls the Establishment of Replication Complexes
Douglas Ross-Thriepland,* Jamel Mankouri, Mark Harris
School of Molecular and Cellular Biology, Faculty of Biological Sciences, and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom
ABSTRACT
The hepatitis C virus (HCV) nonstructural 5A (NS5A) protein is highly phosphorylated and involved in both virus genome repli-
cation and virion assembly. We and others have identified serine 225 in NS5A to be a phosphorylation site, but the function of
this posttranslational modification in the virus life cycle remains obscure. Here we describe the phenotype of mutants with mu-
tations at serine 225; this residue was mutated to either alanine (S225A; phosphoablatant) or aspartic acid (S225D; phosphomi-
metic) in the context of both the JFH-1 cell culture infectious virus and a corresponding subgenomic replicon. The S225A mu-
tant exhibited a 10-fold reduction in genome replication, whereas the S225D mutant replicated like the wild type. By confocal
microscopy, we show that, in the case of the S225A mutant, the replication phenotype correlated with an altered subcellular dis-
tribution of NS5A. This phenotype was shared by viruses with other mutations in the low-complexity sequence I (LCS I), namely,
S229D, S232A, and S235D, but not by viruses with mutations that caused a comparable replication defect that mapped to do-
main II of NS5A (P315A, L321A). Together with other components of the genome replication complex (NS3, double-stranded
RNA, and cellular lipids, including phosphatidylinositol 4-phosphate), the mutation in NS5A was restricted to a perinuclear re-
gion. This phenotype was not due to cell confluence or another environmental factor and could be partially transcomplemented
by wild-type NS5A. We propose that serine phosphorylation within LCS I may regulate the assembly of an active genome replica-
tion complex.
IMPORTANCE
The mechanisms by which hepatitis C virus replicates its RNA genome remain poorly characterized. We show here that phos-
phorylation of the viral nonstructural protein NS5A at serine residues is important for the efficient assembly of a complex that is
able to replicate the viral genome. This research implicates cellular protein kinases in the control of virus replication and high-
lights the need to further understand the interplay between the virus and the host cell in order to develop potential avenues for
future antiviral therapy.
Hepatitis C virus (HCV) currently infects an estimated 170million individuals worldwide and in 85% of cases establishes
a chronic infection, which typically progresses to liver cirrhosis
and hepatocellular carcinoma (1). The virus has a single-stranded
RNA genome that codes for an 3,000-amino-acid polyprotein
that is cleaved co- and posttranslationally into 10 mature viral
proteins: the core and the E1 and E2 envelope proteins, which
make up the viral particle, followed by the viroporin p7 and the
nonstructural 2 (NS2) protein, which possesses autoprotease ac-
tivity. The remaining nonstructural (NS) proteins, NS3, NS4A,
NS4B, NS5A, and NS5B, are necessary and sufficient for genome
replication (2). With the advent of the full-length clone of a geno-
type 2a isolate (JFH-1) able to undergo the complete virus life
cycle in cell culture, significant progress has been made in under-
standing how the different viral proteins contribute to the pro-
cesses of genome replication and virus assembly. In this regard,
NS5A has been shown to play a critical role in both of these pro-
cesses and is known to perturb numerous host pathways in favor
of virus persistence.
The 5= untranslated region (UTR) of the viral genome contains
an internal ribosome entry sequence (IRES) that allows viral pro-
teins to be translated in a cap-independent fashion immediately
after the viral genome is delivered into the cytoplasm. HCV
proteins then rapidly recruit and remodel endoplasmic reticu-
lum-derived membranes to form a membranous web (MW), a
subcellular structure comprised of single-membrane, double-
membrane, and multimembrane vesicles (SMVs, DMVs, and
MMVs, respectively) that are enriched in viral (e.g., NS3, NS5A,
and NS5B) and host cell (e.g., VAP-A) proteins (3, 4). By analogy
to other positive-sense RNA viruses, this enrichment of viral NS
proteins, the presence of double-stranded RNA (dsRNA), and the
observation that isolated membrane fractions retain replication
activity have led to the proposal that the MW is the site of viral
genome replication (3). In Huh7 cells, the MW is extensively dis-
tributed throughout the cytoplasm, correlating with the observed
subcellular distribution of the NS5A and NS3 proteins as discrete
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puncta throughout the cytoplasm. The formation and mainte-
nance of the MW have been shown to be dependent on the acti-
vation of the phosphatidylinositol 4-kinase (PI4K) type III alpha
(PI4KIII) isoform by NS5A and the subsequent elevated produc-
tion of phosphatidylinositol 4-phosphate (PI4P) by this lipid ki-
nase (5–7). Additionally, lipid droplets (LDs) are a host organelle
responsible for the normal cellular storage of neutral lipids and
have been shown to be central to the HCV life cycle. While the site
of virus assembly has not been elucidated, it is known that both the
core and NS5A proteins coat the surface of LDs, displacing the
host factor adipocyte differentiation-related protein (ADRP). In
order for virus genomes that have been newly synthesized in the
MW to be packaged into virions, the core protein-coated LDs are
thought to be recruited to the MW, possibly in an NS5A-directed
manner, in order to allow the encapsidation of viral RNA (8, 9).
NS5A is a highly phosphorylated protein comprised of three
domains and tethered to membranes by an N-terminal amphi-
pathic helix. Domain I is highly structured and sufficient for NS5A
to dimerize, while domains II and III are intrinsically disordered
but have recently been shown to have elements of transient sec-
ondary structure throughout (10–12). These three domains are
linked by low-complexity sequences (LCSs) (13); a serine-rich
sequence (LCS I) links the first two domains, while a proline-rich
sequence (LCS II) links the last two domains. NS5A exists in two
different phosphorylated forms that can be readily resolved by
SDS-PAGE. These forms, termed the basal phosphorylated and
hyperphosphorylated species, are thought to represent different
functional pools of NS5A involved in different stages of the virus
life cycle, but as yet there is little direct evidence to support this
hypothesis. Until recently, the sites of NS5A phosphorylation had
not been unambiguously mapped, their locations having been in-
ferred from mutagenesis data. Recently, however, we and others
have used mass spectrometry to demonstrate that NS5A, purified
from cells actively replicating the HCV subgenomic replicon
(SGR), is extensively phosphorylated within LCS I, containing at a
minimum seven phosphorylation sites (14–16). We also showed
that NS5A contains phosphorylation sites in domain I, domain II,
and LCS II. Previous work to characterize the role of LCS I phos-
phorylation has focused almost entirely on a role in virus replica-
tion and/or assembly/release, and numerous studies have shown
several serines to be important for viral replication, but in a geno-
type-dependent manner. These studies have, however, not ex-
plored the mechanism through which the phosphorylation of LCS
I might be acting.
We show here that the phosphorylation of serine 225 within
LCS I is critical for the correct localization of viral proteins during
infection. Ablation of serine 225 phosphorylation results in a 10-
fold reduction in replicative fitness. We show using confocal mi-
croscopy that this phenotype is concomitant with a dramatic re-
localization of both cellular and viral factors known to participate
in genome replication. This phenotype is shared with mutants
with other serine mutations in LCS I, further illustrating the com-
plexity of phosphorylation in the region of NS5A.
MATERIALS AND METHODS
Plasmids. DNA constructs of and the full-length pJFH-1 virus (17) and
the luciferase subgenomic replicon (SGR-luc-JFH-1) (18) were used
throughout the study. Previously, the unique restriction sites flanking
NS5A, BamHI and AfeI, were introduced into both the full-length virus
and SGR-luc-JFH-1 constructs; these constructs are denoted mJFH-1 and
mSGR-luc-JFH-1, respectively, and have shown been to have no effect on
virus genome replication or assembly and release (19). Site-directed mu-
tagenesis of NS5A was performed with a QuikChange kit (Stratagene) and
a LITMUS28i (NEB) subclone containing an NsiI/HindIII fragment of the
mJFH-1 cDNA. Then, mutant NS5A was cloned into either mSGR-luc-
JFH-1 or mJFH-1 via flanking BamHI/AfeI sites, and correct insertion was
confirmed by sequencing. For the insertion of the SNAP and CLIP tags
into NS5A, the gene was amplified from the pSNAPf and pCLIPf vectors
(NEB) using primers that insert a flexible linker sequence (GSSGSS) on
either side of the insertion (primer sequences are available upon request).
This amplicon was inserted into the aforementioned LITMUS28i sub-
clone by BclI digestion, and correct insertion was verified by sequencing.
The NS5A-SNAP or NS5A-CLIP region was then inserted into mSGR-
luc-JFH-1 via flanking RsrII/AfeI sites. For plasmid expression, mutated
NS5A-coding sequences were subcloned into the pCMV(NS3-5B) vector
as described previously (20). All mutations were verified by sequencing.
Cell culture. Huh7 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM; Sigma) supplemented with 10% fetal bovine serum
(FBS), 100 IU penicillin/ml, 100 g streptomycin/ml, and 1% nonessen-
tial amino acids in a humidified incubator at 37°C with 5% CO2.
Electroporation of replicon and virus RNA constructs. The prepara-
tion of in vitro transcripts and electroporations for both mSGR-luc-JFH-1
and mJFH-1 were conducted as described previously (20). In brief, 2 
106 Huh7 cells in diethyl pyrocarbonate (DEPC)–phosphate-buffered sa-
line (PBS) were electroporated with 5 g of in vitro RNA transcripts using
a square-wave protocol at 260 V for 25 ms. Subsequently, cells were re-
suspended in complete DMEM and seeded at 1  104 cells/cm2 culture
area in either 12- or 6-well dishes.
Virus titration. Supernatants were titrated on Huh7 cells in a 96-well
format as follows. Clarified virus supernatant was serially diluted 2-fold in
complete DMEM before addition of 100 l to cells that had been seeded 8
h earlier at 8  103 cells/well (final volume, 200 l). The counting of
infected cells was automated by acquisition and analysis using an
IncuCyte ZOOM platform. The virus titer was determined by averaging
the positive cell count from 3 or more adjacent counted wells that gave the
corresponding titers.
SDS-PAGE/Western blotting. Cells were washed twice in PBS, lysed
in 1 Glasgow lysis buffer (GLB; 1% [vol/vol] Triton X-100, 120 mM
KCl, 30 mM NaCl, 5 mM MgCl2, 10% [vol/vol] glycerol, 10 mM PIPES
[piperazine-N,N=-bis(2-ethanesulfonic acid)]-NaOH, pH 7.2, with pro-
tease and phosphatase inhibitors), and clarified by centrifugation at
2,800  g for 5 min at 4°C, before determining and normalizing the
protein concentration by a bicinchoninic acid assay (Pierce). Following
separation by SDS-PAGE, proteins were transferred to a polyvinylidene
difluoride (PVDF) membrane and blocked in 50% (vol/vol) Odyssey
blocking (OB) buffer (LI-COR) in PBS. The membrane was incubated
with primary antibodies overnight at 4°C, followed by incubation with
secondary antibodies for 2 h at room temperature (RT); both primary and
secondary antibodies were prepared in 50% OB buffer. The primary
antibodies used were anti-NS5A (sheep, 1:5,000) (21), anti-NS3 (sheep,
1:2,000; prepared in-house), and anti-glyceraldehyde-3-phosphate dehy-
drogenase (anti-GAPDH; mouse, 1:20,000; Sigma). Secondary antibodies
were anti-goat (800 nm) or anti-mouse (700 nm), which were used at
1:5,000, prior to imaging fluorescence using a LI-COR Odyssey Sa infra-
red imaging system. Quantification of fluorescently labeled Western blots
was carried out using Image Studio (v3.1) software (LI-COR) and a back-
ground subtraction method.
Immunofluorescence and confocal microscopy. Cells were washed
once in PBS before fixation for 20 min in 4% (wt/vol) paraformaldehyde
(PFA). The cells were subsequently permeabilized in 0.2% (vol/vol) Tri-
ton X-100 –PBS before immunostaining with the antibody denoted be-
low. The primary antibodies used were anti-NS5A (sheep, 1:1,000), anti-
NS3 (sheep, 1:300; prepared in-house), anti-dsRNA (mouse, 1:200;
Scicons), and anti-PI4P (mouse, 1:100; Echelon). Various fluorescently
conjugated secondary antibodies were used at 1:1,000 (Life Technology).
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Note that when conducting immunostaining for dsRNA, all reagents were
prepared to be RNase free by DEPC treatment. Lipid droplets were stained
using the BODIPY(558/568)-C12 dye at 1:1,000 (Life Technology), which
was added at the same time as the fluorescent secondary antibody. Con-
focal microscopy images were acquired on a Carl Zeiss LSM 700 inverted
microscope, and postacquisition analysis was conducted using either
Zeiss Zen 2012 or Fiji (v1.49) software (22).
In-cell labeling of the SNAP/CLIP tag. Huh7 cells harboring SNAP/
CLIP replicons were fixed in 4% PFA and permeabilized in 0.2% Triton
X-100 –PBS to which 0.9 mM CaCl2 and 0.5 mM MgCl2 were added
(PBS). The SNAP and CLIP substrates were dissolved to 1 mM in
dimethyl sulfoxide, before a 1 M SNAP/CLIP labeling solution was pre-
pared in PBS containing 10% (vol/vol) FBS and added to cells for 2 h
at RT. For immunostaining of NS5A, antibody was added to SNAP/CLIP
labeling solution, followed by secondary antibody staining, as detailed
above.
Quantification of lipid droplets. For quantification of the LD spatial
arrangement, images were acquired by use of the same acquisition param-
eters described above, but a variable gain was used to ensure the correct
exposure. The spatial coordinates of the LDs were determined using the
FindFoci function of the GDSC plug-in for Fiji software, with the nuclear
envelope being manually outlined (utilizing DAPI [4=,6-diamidino-2-
phenylindole] staining as a reference), and the coordinates were generated
by Fiji. The distance from each lipid droplet to the nuclear envelope was
then determined using trigonometry. LD spatial distribution data were
generated for 12 randomly selected cells for each JFH-1 virus variant, and
data were combined into a box-and-whisker plot (see Fig. 3E).
Statistics. Data sets were analyzed using Student’s t test, assuming a
two-tailed, unequal variance to determine statistically significant differ-
ences from the results for the wild type (WT) (n  3 or greater through-
out).
RESULTS
Phosphorylation of serine 225 is important for genome replica-
tion but not assembly of infectious virus. Previously, we identi-
fied serine 225 to be one of a number of serines within the LCS I of
NS5A that is phosphorylated during the normal course of infec-
tion. To investigate the role of serine 225 phosphorylation in the
virus life cycle, we generated either a phosphoablatant alanine
substitution or a phosphomimetic aspartic acid substitution at
this residue in the context of both the mSGR-luc-JFH-1 and
mJFH-1 constructs by site-directed mutagenesis, as described pre-
viously (16). Huh7 cells were then electroporated with in vitro
transcripts of mSGR-luc-JFH-1, and genome replication was fol-
lowed over 72 h by determination of luciferase activity. As seen
previously (16), the phosphoablatant mutation S225A resulted in
a 10-fold reduction in genome replication efficiency, while the
phosphomimetic mutation S225D had no discernible effect (Fig.
1A). To investigate whether the phosphorylation of serine 225 had
additional effects on the release of infectious virus, in vitro tran-
scripts of the mJFH-1 virus with the S225A/D mutations were
electroporated into Huh7 cells, and the titer of the released virus
was followed over 144 h by a focus-forming assay. Figure 1B shows
that the S225A mutant virus had about a 10-fold reduction in
infectious virus compared to the WT, while the S225D mutant
virus had titers indistinguishable from those of the wild type. This
reduction in the titer of released S225A mutant virus correlated
with the impairment of replication, in line with the findings of
previous studies showing that genome replication is the rate-lim-
iting step in the release of infectious virus (23). These data illus-
trate that, as previously concluded (16), phosphorylation of serine
225 is important for viral genome replication but not required for
the release of infectious virus.
Cell lysates from infected cells were collected at 96 and 144 h
postelectroporation (hpe), normalized for protein concentration,
and analyzed by SDS-PAGE/Western blotting. It was found that
there was a reduction in the level of cellular NS5A to a degree
comparable to the reduction in the level of virus replication (Fig.
1C); quantification of the Western blot confirmed this (Fig. 1D).
However, when the ratio of hyperphosphorylation to basal phos-
phorylation was determined, it was found that the S225A mutant
exhibited a reduction in the extent of hyperphosphorylation at
both early and late time points (Fig. 1D). This correlated with the
involvement of the LCS I in hyperphosphorylation previously re-
ported by us and others (14–16).
It was noted that when the protein concentration was normal-
ized for SDS-PAGE, cells infected with the S225A mutant virus
were growing at a higher rate than wild-type virus- and S225D
mutant virus-infected cells (data not shown). To account for this,
the titer of the released virus at 96 and 144 hpe was normalized to
the cellular protein concentration, used here as a surrogate for cell
number, and it was observed that the S225A mutant still exhibited
an approximately 10-fold reduction in the amount of virus re-
leased compared to that for the wild type (Fig. 1E). To ensure that
cell confluence (known to negatively affect HCV replication) was
not affecting the titers of the released virus, electroporated cells
were also passaged at 96 hpe, and at 144 hpe, the titer of the re-
leased virus was determined and normalized to the cellular pro-
tein concentration (Fig. 1E). As noted above, the S225A mutant
exhibited a 10-fold reduction in the amount of virus released com-
pared with that for the wild type.
Ablation of serine 225 phosphorylation alters the subcellular
distribution of NS5A. When virus was titrated by a focus-forming
assay, the subcellular distribution of NS5A with the S225A muta-
tion [NS5A(S225A)] was observed to be markedly different from
that of the wild-type protein. Typically in wild-type JFH-1-in-
fected cells, NS5A was present throughout the cytoplasm in dis-
crete puncta; however, in cells infected with the S225A mutant
virus, NS5A localized into defined, condensed structures. To in-
vestigate this further, Huh7 cells were electroporated with in vitro
transcripts of mJFH-1 virus (the wild type and the S225A and
S225D mutants), fixed at 96 hpe, and immunostained for NS5A as
described above. As described above, wild-type NS5A was distrib-
uted into small, discrete puncta that were abundant and relatively
uniformly distributed throughout the cytoplasm (Fig. 2A). In
contrast NS5A(S225A) exhibited bright, condensed clusters that
were less abundant and typically localized around the nucleus
(Fig. 2B). Importantly, the virus with the S225D phosphomimetic
mutation exhibited a wild-type phenotype (Fig. 2C), strongly sug-
gesting that the phosphorylation of serine 225 is important for the
normal subcellular localization of NS5A.
The S225A mutation results in relocalization of genome rep-
lication complexes. We then asked whether the relocalization of
NS5A(S225A) resulted in any changes to the distribution of other
viral and cellular markers of replication complexes. First, we
looked at the distribution of lipid droplets (LDs), which serve as a
neutral lipid reservoir for the host and have previously been
shown to be an essential host factor involved in HCV replication,
with both the NS5A and core proteins localizing to their surface in
infected cells (9). In the case of both the wild-type virus and the
two mutant JFH-1 viruses, NS5A colocalized to the periphery of
LDs (Fig. 3A to C), and the distribution of the LDs correlated with
that of NS5A. Specifically, in cells infected with the S225A mutant
Phenotype of NS5A Serine Phosphorylation
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virus, LDs clustered close to the nucleus, whereas in the context of
either wild-type or S225D mutant infection, the LDs were more
evenly distributed throughout the cytoplasm. In uninfected cells,
the distribution of LDs more closely resembled that in wild-type-
or S225D mutant-infected cells (Fig. 3D).
To quantify this LD redistribution, we acquired images of 12
randomly selected cells for the wild type and each virus mutant
and quantified both the number of LDs and their distance from
the nuclear membrane. With this quantitative approach, we saw
that in comparison to uninfected cells, wild-type virus-infected
cells exhibited a broader distribution throughout the cytoplasm,
whereas in the context of the S225A mutation, there was a signif-
icant shift of LDs toward the nucleus (Fig. 3E). Interestingly, how-
ever, cells infected with virus with the S225D mutation had an
intermediate phenotype that resembled that of uninfected cells,
where there was a slight shift of LDs toward the nucleus, indicating
that this mutation was not quite fully able to recapitulate the effect
of phosphorylation at serine 225, at least with respect to the LD
distribution (Fig. 3E). With these data, we were also able to inter-
rogate the total number of LDs per cell. There was about a 2-fold
increase in the number of LDs in cells infected with either wild-
type virus or the S225D mutant viruses compared to the number
in naive cells (Fig. 3E). This was not the case for the S225A mutant,
where the number of LDs per cell for S225A mutant-infected cells
was broadly comparable to that for uninfected cells (Fig. 3E), sug-
gesting that NS5A(S225A) is unable to increase the formation of
LDs upon infection.
The viral protease/helicase NS3 is another key component of
genome replication complexes; therefore, to further investigate
the potential redistribution of these complexes caused by the
S225A mutation, we costained infected cells with antibodies to
both NS5A and NS3. As expected, NS3 extensively colocalized
with NS5A in all cases, such that in the context of NS5A(S225A) it
exhibited a restricted perinuclear distribution, whereas for both
wild-type NS5A and NS5A with the S225D mutation [NS5A
(S225D)], NS3 was extensively distributed throughout the cyto-
plasm (Fig. 4A). A similar phenotype was observed for the distri-
bution of double-stranded RNA (dsRNA), a hallmark of viral
genome replication that can be detected using a specific antibody,
J2 (24). As shown in Fig. 4B, in cells infected with mJFH-1, the
dsRNA antibody detected small, bright puncta, typically of a uni-
form size and with a distribution throughout the cytoplasm. In
FIG 1 Characterization of the serine 225 phosphorylation site. (A) Huh7 cells were electroporated with in vitro transcripts of the indicated mSGR-luc-JFH-1
genomes, seeded into plates with a 96-well format, and incubated for 4, 24, 48, and 72 hpe. Luciferase activity was determined at 24, 48, and 72 hpe and normalized
to the value at 4 hpe. (B) Huh7 cells were electroporated with in vitro transcripts of the indicated mJFH-1 virus genomes and seeded into plates with a 6-well
format, cell supernatant was harvested at the denoted time points, and the titer of the released virus was subsequently determined by a focus-forming assay. (C)
At 96 and 144 hpe, cells from the assay whose results are presented in panel B were lysed and analyzed by SDS-PAGE/Western blotting. (D) Total NS5A levels and
the ratio of hyperphosphorylation to basal phosphorylation were quantified from fluorescent Western blots. (E) In order to account for the differences in cell
growth rate, the titer of the released virus was normalized to the total protein concentration, and cells were also passaged 1:4 at 96 hpe before harvesting the
supernatants of the released virus at 144 hpe. ffu, focus-forming units.
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cells electroporated with a replication-defective mutant (GND),
however, there was little to no reactivity toward the dsRNA anti-
body, suggesting that this staining was specific to cells undergoing
virus genome replication (Fig. 4B). Furthermore, this dsRNA
staining could be observed at very early time points postinfection
(24 h), further supporting the notion that these puncta are active
replication complexes and are not the result of the accumulation
of structured RNA in stress granules (data not shown). While the
distribution of dsRNA-positive puncta was not as extensive as that
of lipid droplets (Fig. 3) or NS3 (Fig. 4A), it again correlated with
the distribution of NS5A. Thus, in cells infected with either wild-
type or S225D mutant viruses, dsRNA-positive puncta could be
seen throughout the cytoplasm, whereas in cells infected with the
S225A mutant virus, they were less numerous and restricted to a
perinuclear distribution. The limited distribution of the dsRNA-
positive puncta may be a consequence of the lack of sensitivity of
the antibody or may indicate that there are only a limited number
of active replication complexes and that the number of active rep-
lication complexes is much less than the total number of struc-
tures containing NS3 and NS5A.
Lastly, we investigated the distribution of a host cell factor, the
phospholipid phosphatidylinositol 4-phosphate (PI4P). It has
been well established that infection by HCV and many other RNA
viruses results in the increased production of PI4P lipids, and it is
widely accepted that this is one of the mechanisms through which
HCV is able to induce the formation of the membranous web
(5–7). Using an antibody specific to PI4P, we showed that in cells
infected with wild-type or S225D mutant viruses, PI4P levels were
elevated in comparison to those in uninfected cells (data not
shown) and that there was a strong colocalization between NS5A
and PI4P, with PI4P typically forming small irregular puncta (Fig.
4C). In contrast, cells infected with the S225A mutant virus
showed a dramatic reduction in the abundance of PI4P puncta
and their relocalization to a perinuclear distribution along with
NS5A (Fig. 4C).
From the findings of this confocal microscopy and immuno-
fluorescence analysis, we conclude that the phosphoablatant mu-
tation S225A in NS5A is sufficient to induce the relocalization of
numerous factors associated with HCV genome replication. It is
important to note that we did not observe a loss of colocalization
of NS5A with these factors, reflecting the fact that NS5A(S225A)
retained the ability to replicate and release infectious virus.
The relocalization of NS5A(S225A) and viral/host factors is
not a result of reduced HCV replication. It was important to
establish that the phenotype of reduced HCV replication was spe-
cifically the result of the loss of phosphorylation at serine 225 and
not the result of the lower levels of replication (and, so, viral pro-
teins) that are observed with virus containing NS5A with the
S225A mutation. To achieve this, we utilized two previously char-
acterized mutations within domain II of NS5A, P315A and L321A,
that had previously been shown to impair (approximately 10-
fold) virus replication similarly to S225A (20).
As expected, an approximately 10-fold reduction in the
amount of virus that was released was exhibited for both the mu-
tant virus containing NS5A with the P315A mutation [NS5A
(P315A)] (Fig. 5A) and the mutant virus containing NS5A with
the L321A mutation [NS5A(L321A)] (data not shown); this
amount was comparable to that achieved with virus with the
S225A mutation, confirming that the S225A, P315A, and L321A
mutations impair virus replication to similar levels. Both mutant
viruses exhibited a reduction in the levels of NS5A expression
similar to that seen for virus with the S225A mutation (Fig. 5B and
C and data not shown) and exhibited a ratio of NS5A hyperphos-
phorylation to basal phosphorylation similar to that for the wild
type (Fig. 5C and data not shown) but different from that for both
S225 mutants, consistent with the previously proposed notion
that S225 is a site of phosphorylation in the hyperphosphorylated
species of NS5A (16). Therefore, if the phenotype of NS5A relo-
calization was the result of reduced replication, it would be ex-
pected that both the P315A and L321A mutants would show the
same phenotype.
Huh7 cells infected with mutant viruses with the NS5A
(P315A) (Fig. 5D) or NS5A(L321A) (data not shown) mutation
were analyzed by confocal microscopy for the abundance and dis-
tribution of NS5A and LDs. Reassuringly, the distribution of
NS5A in cells infected with these mutants was indistinguishable
from that in cells infected with the wild type, with no evidence of
the restriction to a perinuclear distribution. Quantitative analysis
revealed no significant difference between the wild type and the
two mutants with regard to the distance of the LDs from the nu-
FIG 2 Subcellular distribution of wild-type NS5A and NS5A with mutations
at serine 225 in JFH-1-infected cells. Huh7 cells were electroporated with in
vitro transcripts of either wild-type mJFH-1 (A) or the NS5A(S225A) (B) or
NS5A(S225D) (C) mutant, and the cells were seeded onto coverslips and in-
cubated for 96 h prior to fixation, immunostaining for NS5A (sheep, 1:1,000),
and imaging by confocal microscopy. Panels a to d on the right are higher
magnifications of the corresponding boxed areas in the wide-field images.
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clear membrane (Fig. 5E). Similar results were seen for the distri-
bution of NS3 and PI4P (Fig. 5D), as well as for that of dsRNA
(data not shown). It is noteworthy that although the distribution
of PI4P lipids in NS5A(P315A) virus-infected cells was similar to
that in wild type-infected cells, there was an obvious reduction in
their quantity, suggesting that this mutation might have an inde-
pendent effect on NS5A-mediated PI4K activation. This observa-
tion notwithstanding, we conclude that the effect of the S225A
mutation on the distribution of replication complex components
cannot be explained by a reduction in replicative fitness; rather, it
is specifically the loss of phosphorylation at serine 225 that is re-
sponsible for this phenotype.
The S225A mutant phenotype does not correlate with a loss
of hyperphosphorylation. Although our original observation was
made during routine virus titration experiments, we had not
screened an entire panel of mutants with serine mutations within
LCS I. Given the complexity of the phosphorylation patterns
within this region and the potential role of S146 in regulating
hyperphosphorylation (16), we therefore generated a complete
panel of mutants with either phosphomimetic or phosphoabla-
tant mutations in all 8 serines in LCS I and S146 and examined
their phenotypes by both virus titration and immunofluores-
cence. Consistent with the findings of our previous analysis (16)
and those of Masaki et al. (15), most mutations had no effect on
virus titer; however, the S225A, S232A, and S235D mutant viruses
all exhibited a significant reduction in titer (approximately 10-
fold) (Fig. 6A). Cells infected with the S232A and S235D mutants
also shared the restricted perinuclear distribution of NS5A and LD
FIG 3 Analysis of lipid droplet redistribution in infected cells. Huh7 cells were electroporated with in vitro transcripts of either wild-type mJFH-1 (A) or the
NS5A(S225A) (B) or NS5A(S225D) (C) mutant or were not infected (D), and cells were seeded onto coverslips and incubated for 48, 72, and 96 hpe prior to
fixation, immunostaining for NS5A and LDs, and imaging by confocal microscopy. Uninfected control cells were also processed at 96 h postseeding. Spatial data
for LDs were determined from 12 cells for each virus using the GDSC plug-in for Fiji. (E) These data were used to determine the number of LDs per cell as well
as the distance of each LD from the nuclear envelope. Box-and-whisker plots show the 10 to 90% distribution. ***, significant difference (P  0.05) from the
results for the wild type.
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FIG 4 Colocalization of NS5A phosphorylation mutants with host and viral factors. Huh7 cells were electroporated with in vitro transcripts of either wild-type
mJFH-1 or the NS5A(S225A) or NS5A(S225D) mutant and seeded onto coverslips. At 96 hpe, cells were fixed and immunostained for NS5A and either NS3 (A),
dsRNA (B), or the phospholipid PI4P (C). An NS5B GND (nonreplicating) control was included for the dsRNA staining. The colocalization scatter plots on the
right are of an area of 200 by 200 m containing 	10 cells and show the correlation of absolute values (x and y axes, pixel numbers). The correlation value (r)
is shown for each image.
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(Fig. 6B). As demonstrated previously (15), the S229D mutation
did not result in the production of any infectious virus; however,
the S229D mutant exhibited limited RNA replication and protein
expression (15, 16), and the distribution of both NS5A and LDs in
S229D mutant-infected cells was again restricted to a perinuclear
region. We conclude that the phosphorylation of different serines
within LCS I can have opposing effects on the subcellular distri-
bution of NS5A.
Lastly, we examined the phenotype of a double mutant, the
S146D and S225D mutant, that we had previously shown repli-
cated as well as the wild type but in which hyperphosphorylation
was almost completely abolished (16). The distribution of NS5A
in cells infected with this mutant was comparable to that in cells
infected with the wild type (see Fig. S1 in the supplemental mate-
rial), confirming that the phenotype of a restricted perinuclear
distribution for the S225A mutant could not be explained by a
defect in hyperphosphorylation. As an aside, none of the mutants
(including the S225A mutant) exhibited any significant differ-
ences in sensitivity to daclatasvir (DCV) from that of the wild type.
The 50% effective concentrations (EC50s) ranged from 10 to 57
pM (in our hands, a wild-type JFH-1 replicon had an EC50 of 57
pM), and although treatment with DCV reduced the abundance
of NS5A, it did not alter the widespread cytoplasmic distribution
(data not shown).
The phenotype of the S225A mutant is not the result of cell
culture conditions. To enable us to interrogate further the phe-
notype of the S225A mutant, we utilized the SNAP and CLIP tag
(NEB) technology. This complementary tag system allows the spe-
cific conjugation of either benzylguanine or benzylcytosine deriv-
atives, typically fluorescently labeled, to the SNAP or CLIP tag,
respectively. This approach has recently been described for NS5A
(25), and we reasoned that it would enable us to differentially label
wild-type NS5A and the S225A and S225D mutants within the
same population of cells. The advantage of the SNAP and CLIP
tags over the traditional green fluorescent protein (GFP) and red
fluorescent protein tags is a combination of the flexibility offered
with the SNAP/CLIP system and the high sequence similarity be-
tween the SNAP and CLIP tags.
The SNAP/CLIP tags were initially introduced into the wild-
type mSGR-luc-JFH-1 replicon (19) at position 431 in NS5A (do-
main III), as this site has previously been shown to tolerate large
insertions (Fig. 7A). We confirmed that the insertion of either tag
FIG 5 An NS5A domain II mutation that impairs replication does not have the same redistribution phenotype as NS5A(S225A). Huh7 cells were electroporated
with in vitro transcripts of either wild-type mJFH-1 or the NS5A(S225A), NS5A(S225D), or NS5A(P315A) mutant. (A) The titer of the released virus was
determined at 96 hpe by a focus-forming assay. The virus titer was normalized to the cellular protein concentration in order to account for differences in cell
growth rates. (B) At 96 hpe, cells were lysed and analyzed by SDS-PAGE/Western blotting for NS5A and GAPDH. (C) Total NS5A levels and the ratio of
hyperphosphorylation to basal phosphorylation were quantified from fluorescent Western blots. (D) At 96 hpe, electroporated cells were fixed and immuno-
stained for NS5A and either LDs, PI4P, or NS3, as described in the legend to Fig. 4. (E) Spatial data for LDs were determined from 12 cells for each virus using
the GDSC plug-in for Fiji. Box-and-whisker plots show the 10 to 90% distribution. ***, significant difference (P  0.05) from the results for the wild type.
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had no discernible effect on the replication kinetics of the mSGR-
luc-JFH-1 replicon compared to those of the untagged wild-type
replicon (Fig. 7B). As the SNAP and CLIP tags share very high
sequence similarity yet retain different substrate specificities, it
was important to establish that the insertion of the tag at an inter-
nal position did not introduce conformation changes that affected
the substrate specificity. As such, cells harboring the mSGR-luc-
JFH-1-NS5A-SNAP (NS5A-SNAP) replicon were fixed at 72 hpe,
immunostained for NS5A, and labeled with a CLIP-tetramethyl-
rhodamine (TMR) fluorophore. The converse, where the mSGR-
luc-JFH-1-NS5A-CLIP (NS5A-CLIP) replicon was labeled with
the SNAP-TMR fluorophore, was also carried out. Figure 7D
FIG 6 Mutants with other serine mutations in LCS I share the condensed redistribution phenotype with the S225A mutant. (A) Huh7 cells were electroporated
with in vitro transcripts of either wild-type mJFH-1 or the indicated mutants. The titer of released virus was determined at 96 hpe by a focus-forming assay. (B)
At 96 hpe, electroporated cells were fixed and immunostained for NS5A and LDs, as described in the legend to Fig. 3. Only the results for the three mutants that
shared the phenotype are shown here for comparison with the wild type. See Fig. S1 in the supplemental material for the complete data set. (C) Summary table
of mutant phenotypes. n.a., not available (did not replicate). (D) Amino acid sequence of LCS I. *, serine residues with a redistribution phenotype; DI, DII, and
DIII, domains I, II, and III, respectively.
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shows that both the SNAP and CLIP tags retained both catalytic
activity and specificity toward the appropriate SNAP/CLIP sub-
strate, with SNAP-TMR labeling only NS5A-SNAP and CLIP-
TMR labeling only NS5A-CLIP. The corresponding immuno-
staining for NS5A also showed a very high degree of correlation,
confirming that there was no subpopulation of either NS5A-
SNAP or NS5A-CLIP that was not labeled with the SNAP/CLIP
substrates.
We proceeded to use the SNAP/CLIP system to establish
whether there was a hitherto unknown environmental factor that
was inducing the phenotype of the S225A mutant. To do this, we
generated mSGR-luc-JFH-1-NS5A(S225A)-SNAP [NS5A(S225A)-
SNAP]andmSGR-luc-JFH-1-NS5A(S225D)-CLIP[NS5A(S225D)-
CLIP] replicons. As shown in Fig. 7B, these two mutants retained
their replication phenotypes (a 10-fold impairment of replication
for the S225A mutant and wild-type replication for the S225D
mutant) when expressed as SNAP/CLIP fusions. Analysis of cell
lysates by Western blotting showed an abundance and hyperphos-
phorylation/basal phosphorylation ratios of NS5A comparable to
those observed for the untagged mutants (Fig. 7C). As seen in the
context of virus-infected cells (Fig. 3 and 4), cells harboring the
NS5A(S225A)-SNAP replicon exhibited both a reduced abun-
dance and a restricted perinuclear distribution of NS5A (Fig. 7E)
in comparison to those for cells harboring either the wild-type
(SNAP tagged) or the NS5A(S225D)-CLIP replicon.
To confirm that the S225A phenotype was not due to an envi-
ronmental factor, such as differences in cell confluence, we elec-
troporated either mSGR-luc-JFH-1-NS5A-CLIP or mSGR-luc-
JFH-1-NS5A(S225A)-SNAP replicon RNAs into Huh7 cells and
coseeded the electroporated cells into single cultures. By confocal
microscopy, we observed that within the same population of cells,
in the same field of view, those harboring the wild-type NS5A-
CLIP replicon had a normal distribution of NS5A, while those
harboring the NS5A(S225A)-SNAP replicon continued to show
the restricted NS5A localization (Fig. 8A).
To further investigate the NS5A(S225A) phenotype, we uti-
lized the SNAP/CLIP tag technology to ask if NS5A(S225A) could
be transcomplemented by wild-type NS5A. In our experience, the
simultaneous introduction of two replicons into a single cell is a
rare event, for reasons that are not clear, particularly given the
ratio of RNA molecules to cells in a typical electroporation exper-
iment. However, after coelectroporation of mSGR-luc-JFH-1-
NS5A-CLIP and mSGR-luc-JFH-1-NS5A(S225A)-SNAP replicon
RNAs into Huh7 cells, we did observe some cells that were stained
with both SNAP-505 and CLIP-TMR fluorophores, consistent
with the presence of both actively replicating replicons in a single
cell. In these cells, we observed two distinct phenotypes: either the
presence of wild-type NS5A-CLIP was sufficient to restore the
localization of NS5A(S225A)-SNAP to that of the wild type, re-
sulting in a broad distribution of both and high levels of colocal-
ization (Fig. 8B), or the distribution of NS5A(S225A)-SNAP re-
mained in bright, condensed, and amorphous structures, with
wild-type NS5A-CLIP being distributed normally throughout the
same cell (Fig. 8C).
DISCUSSION
We present here the results of our investigation of the phenotype
of mutants with mutations at residue serine 225 in NS5A of JFH-1.
We propose that the phosphorylation of serine 225 is important
for genome replication; mutation of this residue to alanine
FIG 7 Generation and validation of mSGR-luc-JFH-1 replicons containing
either NS5A-SNAP or NS5A-CLIP fusions. (A) Schematic of the mSGR-luc-
JFH-1 replicon showing the region of NS5A where the SNAP/CLIP tag was
inserted, along with the flanking, flexible linker sequences. The amino acid
numbering is for JFH-1 NS5A. (B) Huh7 cells were electroporated with the
indicated mSGR-luc-JFH-1 replicon RNAs, and replication was followed over
72 h by determining luciferase activity, which is shown normalized to the
activity at 4 hpe. (C) Cells were lysed at 72 hpe and analyzed by SDS-PAGE/
Western blotting for NS5A and GAPDH. A nonspecific band (ns) was seen at
equal levels in all lysates (D). Huh7 cells electroporated with the NS5A-SNAP
(left) or NS5A-CLIP (right) replicon RNAs were also seeded onto coverslips
and at 72 hpe were fixed and immunostained for NS5A, as well as labeled with
either SNAP-TMR or CLIP-TMR, before imaging by confocal microscopy. (E)
Huh7 cells electroporated with the indicated mSGR-luc-JFH-1 replicon RNAs
were seeded onto coverslips, fixed at 96 hpe, and immunostained for NS5A.
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(S225A) resulted in a relocalization of NS5A and other compo-
nents of the HCV genome replication complex (NS3, dsRNA, and
PI4P lipids) to a perinuclear distribution, in comparison to either
wild-type or a phosphomimetic (aspartic acid) substitution
(S225D). This altered subcellular localization was accompanied
by a 10-fold reduction in genome replication compared with the
level of replication of wild-type or S225D mutant virus. This phe-
notype, together with the reduction in genome replication, was
shared with mutants with three other mutations in LCS I (S229D,
S232A, and S235D) but, importantly, was not seen for other NS5A
mutants with a similar replication defect (P315A and L321A mu-
tations). These data are consistent with serine phosphorylation in
LCS I either positively (phosphorylation at S225 and S232) or
negatively (phosphorylation at S229 and S235) regulating the for-
mation and distribution of replication complexes. This conclu-
sion also fits well with the concept of a phosphorylation-mediated
switch of NS5A functions between replication and virus assembly,
although the mechanics of such a switch remain elusive. Intrigu-
ingly, S232 corresponds to the residue which was the target for a
dramatic culture adaptation (20,000-fold) in the context of geno-
type 1b replicons (S2204I in polyprotein numbering). Despite the
conservation of the sequence of LCS I between HCV genotypes,
these observations suggest that this does not manifest in a con-
comitant conservation of function, as neither we (Fig. 6A) nor
others (15) have seen any major effect of mutations at this residue
on JFH-1 virus replication. In the future, it will be important to
compare the sites of phosphorylation and phenotypes in HCV
isolates with a range of genotypes to address these questions.
How might the altered distribution of the mutant NS5A be
explained? A clue may come from the experiments examining the
distribution of PI4P lipids (Fig. 4C). PI4P lipids are produced by
PI4K, and previous work from other laboratories (5–7) has dem-
onstrated that the PI4KIII isoform is required for HCV genome
replication. Indeed, PI4KIII has been shown to bind to NS5A,
with the binding site mapping to a short region at the C terminus
of domain I (residues 202 to 210) (26), and disruption of this
interaction had a profound effect on replication (100-fold reduc-
tion), blocked the stimulation of PI4P formation, and led to a
collapse of the membranous web. In this regard, the restricted
distribution and clustering of NS5A seen in the context of the
S225A mutation are reminiscent of the NS5A localization seen in
cells silenced for expression of PI4KIII (7). We therefore propose
that the replication defect of S225A may be explained in part by
the inability of this NS5A mutant protein to effectively recruit and
activate PI4KIII. This simplistic explanation is complicated by
the results of experiments in which we expressed NS5A in the
context of an NS3-5B polyprotein from a cytomegalovirus pro-
moter-driven plasmid vector (data not shown). In this situation,
the nonstructural proteins can form a replication complex, but in
the absence of a cognate RNA template, no genome replication
can occur. Intriguingly, under these conditions the S225A pheno-
type is not apparent: the distribution and abundance of both
NS5A and PI4P in transfected cells are very similar for both the
wild type and the S225A mutant. Thus, we would further propose
that the function of S225 phosphorylation in regulating interac-
tions between NS5A and PI4KIII (and/or other cellular compo-
nents) is manifest only in the context of a replication complex that
is actively replicating the viral genome. What is difficult to recon-
cile is the observation that inhibiting the interaction between
NS5A and PI4KIII increased the hyperphosphorylation of NS5A
(26), concomitant with a reduction in virus genome replication.
In contrast, our data show a loss of hyperphosphorylation of
S225A (Fig. 1D), and indeed, our previous data (16) failed to in-
dicate a correlation between hyperphosphorylation and replica-
tion. This discrepancy serves to highlight the complexity of NS5A
phosphorylation, particularly regarding the multiple phosphory-
lation events within LCS I. There is a need to fully characterize
both the kinases involved and the consequences of phosphoryla-
tion to clarify the function of these posttranslational modifica-
tions in the virus life cycle.
An alternative explanation for the restricted distribution of the
S225A mutant NS5A is that it was impaired in its ability to traffic
FIG 8 The redistribution of NS5A(S225A) is not the result of an environmen-
tal factor and can be partially transcomplemented by wild-type NS5A. (A)
Huh7 cells electroporated with either mSGR-luc-JFH-1-NS5A-CLIP or
mSGR-luc-JFH-1-NS5A(S225A)-SNAP RNAs were coseeded onto the same
coverslip, and at 96 hpe, cells were fixed and labeled with either SNAP-505
(green) or CLIP-TMR (red), before imaging by confocal microscopy. (B, C) In
vitro transcripts of mSGR-luc-JFH-1-NS5A-CLIP and mSGR-luc-JFH-1-
NS5A(S225A)-SNAP were pooled prior to coelectroporation into Huh7 cells
and seeding onto coverslips. At 96 hpe, cells were fixed and labeled with SNAP-
505 and CLIP-TMR, prior to imaging by confocal microscopy. (B) Example
of a population of Huh7 cells showing colocalization between wild-type
NS5A(CLIP) and NS5A(S225A)-SNAP. (C) Example of an Huh7 cell showing
a difference in cellular localization between NS5A(CLIP) and NS5A(S225A)-
SNAP. The colocalization scatter plots at the bottom right of panels B and C are
of individual cells and show the correlation of absolute values.
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around the cytoplasm. In an elegant set of experiments using both
tetracysteine and GFP-tagged NS5A-containing viruses, it was re-
cently shown that NS5A was present in two classes of motile struc-
tures. The majority were relatively static, but some exhibited
rapid, long-range, and sporadic movement throughout the cyto-
plasm (25). The rapid movement was shown to involve the micro-
tubule network and was dynein dependent. It is thus formally
possible that NS5A(S225A) is impaired in interactions with mi-
crotubules or dynein, preventing its movement around the cyto-
plasm and leading to its accumulation in the perinuclear region.
However, we do not believe that this is the case because live cell
imaging of either wild-type or S225A/D mutant viruses in which
NS5A was Emerald-GFP (emGFP) tagged did not reveal any gross
differences in the motility of NS5A-positive structures (see Videos
S1 to S3 in the supplemental material). In addition, a defect in
dynein-dependent trafficking might intuitively be expected to re-
sult in a distribution around the periphery of the cell, as dynein
moves toward the minus end of microtubules, which is usually at
the cell center.
The use of the SNAP/CLIP tagging system allowed us to differ-
entially label NS5A(S225A)-SNAP and wild-type NS5A-CLIP
within one population of cells, thereby visualizing in the same field
of view cells that were harboring either S225A or wild-type repli-
cons. Importantly, this analysis demonstrated that the distribu-
tion of NS5A(S225A) was still markedly different from that of the
wild-type protein (Fig. 7E), illustrating that the altered localiza-
tion of NS5A was not due to an environmental factor. However,
the SNAP/CLIP system also revealed that the presence of wild-
type NS5A was able to complement the S225A defect in only a
proportion of cells. This suggests that additional, as yet undefined,
stochastic factors, such as the stage of the cell cycle or the avail-
ability of cellular factors, may contribute to the observed pheno-
type.
In conclusion, this study highlights an important role of phos-
phorylation in regulating the function of NS5A. Clearly, there is
much to do to define the mechanisms underpinning this effect; in
particular, we need to understand the molecular interactions that
are modulated by the phosphorylation of NS5A at serine 225 and
other serines in LCS I. While a number of candidates, such as
PI4KIII, are already apparent, there are many other NS5A-inter-
acting proteins that should be considered, and a proteomics ap-
proach to compare the interactome of both the wild-type and
mutant forms of NS5A is an appropriate way forward. Such ex-
periments are under way in our laboratory.
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